This is better then I expected with the length of time in reporting I was worried there would be a negative in the report. However the onlynegative is they are still working on palatability. So it is steadyas she goes, international attention would always help so good to see UK interest. The isse re SP is investors want commercial viability before anything major can change. So still staying in for me with probably a bigger holding then I should have but no risk no reward. Keep going PAA!!!
Ann: Clinical Trial Report Following Phase I Trial, page-8
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $50.92K | 290.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 152309 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 329859 | 3 |
View Market Depth
| Last trade - 15.48pm 11/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |